US Broker Ratings

Dynavax Technologies (DVAX) Stock Analysis: Exploring the 3.23% Upside Potential in the Burgeoning Vaccine Market

Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the biopharmaceutical sector, is making waves with its focus on developing and commercializing innovative vaccines. With a..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 188% Potential Upside with Strong Buy Ratings

For investors with an eye on biotech, Ocular Therapeutix, Inc. (NASDAQ: OCUL) presents an intriguing opportunity. Specializing in innovative therapies for retinal diseases and other eye..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Strong Revenue Growth and Potential Upside in Medical Devices

Establishment Labs Holdings Inc (NASDAQ: ESTA) is making waves in the healthcare sector, specifically within the medical devices industry. Known for its innovative approach to aesthetic..

Immunovant, Inc. (IMVT) Stock Analysis: A Biotech Play with 57.77% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT) is attracting considerable attention in the investment community, particularly among those with an eye for high-reward opportunities in the biotechnology sector. With..

Merus N.V. (MRUS) Stock Analysis: Biotechnology Gem with 7.78% Potential Upside

Merus N.V. (NASDAQ: MRUS), a Netherlands-based biotechnology firm, stands at a pivotal point in its growth trajectory. Specializing in the development of innovative antibody therapeutics, Merus..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 69.81% Potential Upside

MannKind Corporation (NASDAQ: MNKD), a key player in the biotechnology sector, is garnering significant attention from investors, thanks to its promising pipeline and substantial growth potential...

Perrigo Company plc (PRGO): Valuation Insights Reveal Significant 44% Upside Potential for Investors

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector, stands out in the drug manufacturing industry with its focus on over-the-counter health and..

Disc Medicine, Inc. (IRON) Stock Report: Analyst Consensus Predicts 84.84% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is gaining attention in the healthcare sector for its innovative focus on hematologic diseases. Headquartered in Watertown,..

NeoGenomics, Inc. (NEO) Investor Outlook: Assessing the 27.97% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO) stands as a noteworthy contender within the healthcare sector, specifically in the diagnostics and research industry. With a current market capitalization of..

Pediatrix Medical Group (MD) Stock Analysis: Exploring Growth Potential and Market Position

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the medical care facilities industry, holds a distinctive position within the healthcare sector. With a market..

ANI Pharmaceuticals (ANIP) Stock Analysis: Exploring a 42.84% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) emerges as a compelling opportunity within the healthcare sector, particularly in the high-demand sphere of specialty and generic drug manufacturing. With..

Evotec SE (EVO) Stock Analysis: Navigating a 60% Potential Upside in the Healthcare Sector

Investors keen on the healthcare sector might find Evotec SE (EVO) an intriguing prospect, particularly given its substantial potential upside of 60.43%. Operating out of Germany,..

Liquidia Corporation (LQDA) Stock Analysis: Exploring 1,121.70% Revenue Growth and Strategic Opportunities

Liquidia Corporation (NASDAQ: LQDA) is capturing investor attention with its impressive 1,121.70% revenue growth, positioning itself as a notable player in the biotechnology sector. Headquartered in..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: A 21% Upside Potential Beckons Investors

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, specifically in the medical care facilities industry, offers investors a compelling opportunity with..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a 54% Potential Upside Amidst Robust Buy Ratings

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company headquartered in South San Francisco, California, is capturing investor attention with a compelling potential upside of..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 36% Upside in the Biotechnology Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands at the forefront of innovative biopharmaceutical research, specializing in the discovery and development of cellular metabolism therapies. With a market..

Integra LifeSciences Holdings C (IART) Investor Outlook: Analyzing a 36.93% Potential Upside in the Medical Device Sector

As a player in the competitive medical device industry, Integra LifeSciences Holdings Corporation (NASDAQ: IART) has caught the attention of investors seeking opportunities in the healthcare..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating a 6.43% Potential Upside in Health Information Services

10x Genomics, Inc. (NASDAQ: TXG), a leading player in the health information services industry, is making waves with its cutting-edge technology that revolutionizes the analysis of..

Innoviva, Inc. (INVA) Stock Analysis: Potential 43% Upside Captivates Investors

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, has been drawing attention from investors due to its impressive growth potential and strategic focus..

Azenta, Inc. (AZTA) Stock Analysis: Is a 35.10% Potential Upside Worth Considering?

Azenta, Inc. (NASDAQ: AZTA) is carving a niche in the healthcare sector with its innovative solutions in the medical instruments & supplies industry. Headquartered in Burlington,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds